Wednesday, May 13, 2026
26.4 C
Bengaluru

First Approach in Pharma

[wpfilebase tag=file id=93 tpl=download-button /]

Inside this Issue

1. Incentivizing a Patient-First Approach in Indian Pharma  interview with Annaswamy Vaidheesh
A conversation with Annaswamy Vaidheesh, Vice President, OPPI, VP, South Asia & Managing Director, India, GSK on GSKs initiatives to meet the demands of Indian pharma in the digital age while putting the patient first

2. The Indian Pharma Brand Story: From Independence to Now by Vivek Hattangadi
Vivek Hattangadi traces the story of Indian pharma branding from Independence till today through his personal and professional experiences

3. The Second-line Manager as Both Actor and Architect by Sunder Ramachandran
Operational effectiveness and strategic alignment are the two KPIs for every successful second-line manager

4. To SWOT or not to SWOT by K. Hariram
Understanding the strategic intent behind SWOT analysis

Hot this week

Do Retail Pharmacies Really Care about Patients?

The chemist shop—jammed between a chai stall and a...

Indian Oncology: An Unasked Question, the Challenges Ahead

A Brief History of Scale and an Unasked Question In...

Are Quick Remedies Keeping Patients Away from Doctors?

The recent Mint Lounge analysis captured a striking consumer...

From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey

Abstract The U.S. Food and Drug Administration (FDA) evolved from...

Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader

In a landmark decision for India’s biotechnology sector, Kiran...

Topics

Do Retail Pharmacies Really Care about Patients?

The chemist shop—jammed between a chai stall and a...

Indian Oncology: An Unasked Question, the Challenges Ahead

A Brief History of Scale and an Unasked Question In...

Are Quick Remedies Keeping Patients Away from Doctors?

The recent Mint Lounge analysis captured a striking consumer...

From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey

Abstract The U.S. Food and Drug Administration (FDA) evolved from...

Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader

In a landmark decision for India’s biotechnology sector, Kiran...
spot_img

Related Articles

spot_imgspot_img